Natalia Mazina

Natalia is a tenacious regulatory counsel and an “outside-the-box” thinker offering extensive experience to healthcare providers in the areas of:

  • Government Investigations: DEA, FDA, HHS, Boards of Pharmacy and Medical Boards;
  • Third-Party audits and licensing:  PBMs, Medicaid and Medicare;
  • Compliance: Board of Pharmacy, Medical Board, FDA and DEA regulations, PBM contracts and manuals, HIPAA and state privacy laws, Anti-Kickback statutes and False Claims;
  • License Defense:  pharmacy, pharmacists, doctors, nurses and dentists;
  • Business transactions:  purchase and sale of a practice, partnership agreements and pharmacy formation.

Prior to joining the firm, she was a founding partner of Carman & Mazina, a healthcare law boutique with the focus on representing pharmacies in fraud investigations, disciplinary actions and litigation. She was also an associate for Medicaid Defense Fund (MDF), a non-profit that obtained seven consecutive injunctions to stop Medi-Cal provider reimbursement cuts. Her experience in MDF included writ litigation, appeal, and mediation in states and federal courts. She worked on cases with national and state-wide impact such as: Keffeler v Partnership Healthplan of Cal, 224 Cal.App.4th 322 (Cal Court App 2014); Douglas v Indep. Living Center of So. Cal, 132 S.Ct. 1204 (U.S. Supreme Ct 2012); Managed Pharmacy Care v. Sebelius, 716 F.3d 1235 (Ct Appeals 9th Cir 2013).

EMAIL NATALIA MAZINA

Affiliations and Memberships:

American Society for Pharmacy Law
California Society for Healthcare Attorneys
American Bar Association, Health Law section
The American Health Lawyers Association
California State Bar

Recent Successes & Achievements:

  • Represented a pharmacy in a PBM audit with recoupment claims of over half a million dollars.  Negotiated a favorable outcome for the pharmacy by reducing the recoupment amount by 70% and avoiding contractual termination of the pharmacy;
  • Successfully removed a pharmacy from Suspended and Ineligible Provider List maintained by the Department of Health Care Services within a week after the DHCS included the pharmacy on the list.  Precluded PBMs from terminating contracts with the pharmacy;
  • Dismissed a lawsuit file against a pharmacy early in the proceedings.  Turoci v. Evans et al. (Sup. Ct. Riverside, RIC 1502673).;
  • Favorably settled DEA’s allegations of improper record-keeping and negotiated a favorable outcome for the pharmacy;
  • Dismissed an Accusation against a pharmacy file by the California State Board of Pharamacy;
  • Name a “Lawyer of Distinction” in 2018.

Speaking Engagements:

  • The American Health Lawyers Association, DEA Enforcement Webinar (December 2017)
  • American Bar Association, Health Law Section, “Minimizing risks with controlled substances.” (June 8th, 2017)
  • California Society for Healthcare Attorneys, “What healthcare providers need to know about cannabis (legal perspective).” (April 2017)
  • California Society for Healthcare Attorneys, “Pharmacy Law.  How does it apply to non-pharmacy clients?” (November 2016)
  • American Society for Pharmacy Law, “Overview of PBM regulations and litigation.” (November 2016)
  • Charmalot 2016 Conference: “Legal Issues in TeleMedicine.” (March 2016)
  • Political Solutions’ podcast, “Legal Issues in the Business of Pharmacy,” Episode 218 (guest speaker, May 18, 2015)
  • Political Solutions’ podcast, “Pharmacy Business Law,” Episode 201 (guest speaker, February 16, 2015)
  • Managed Pharmacy Care seminar, “Medi-Cal Reimbursement Issues.” (November 2014)

Publications:

Hobbies and Interests:

  • Founder of Mindful Buyers Network
  • Toastmasters International (several public speaking awards on the club and district level)
  • Languages:  English, Russian, Byelorussian, Spanish
  • Mountain biking
  • Diving
  • International explorer (Central America and India)